Electroacupuncture vs PTNS for women with refractory overactive bladder
Official title: Electroacupuncture as a Treatment for Refractory Overactive Bladder: A Feasibility /Pilot Randomized Controlled Trial
Run by Chelsea and Westminster NHS Foundation Trust · NCT07124390 · Data updated 2026-11-12
This study tests whether electroacupuncture or percutaneous tibial nerve stimulation can help women whose overactive bladder hasn’t improved with standard therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 24 (estimated) |
| Sponsor | Chelsea and Westminster NHS Foundation Trust Academic / other |
| Locations | 1 site (London, United Kingdom) |
| Status | Recruiting |
| Started | August 15, 2026 |
| Main results expected | November 30, 2027 |
| Study ends | December 30, 2027 |
| Registry record updated | August 28, 2026 |
| Trial ID | NCT07124390 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older with overactive bladder refractory to first-line treatments and ICIQ-OAB score ≥10.
✕Probably not a fit
Individuals with pregnancy, active infection, severe needle phobia, a pacemaker, active cancer, or other exclusion criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-site feasibility randomized trial comparing electroacupuncture (EA) with PTNS in women with refractory overactive bladder. Twenty-four participants will be randomized to receive either EA or PTNS over 12 weeks, with follow-up at 6 weeks, 12 weeks, 6 months, and 12 months. The aim is to determine if a larger definitive trial is feasible by examining recruitment, retention, adherence, data completeness, safety, and participant acceptability, to inform future study design. The study sits within a pelvic health physiotherapy service and explores non-pharmacological treatment options for OAB. Outcomes will help clarify whether EA and PTNS merit direct comparison in a larger trial.
Why it matters
Potential benefit: If successful, the trial could support non-drug options for reducing OAB symptoms and improving quality of life.
How similar studies have gone: Prior work suggests neuromodulation approaches can help OAB, but direct comparison between EA and PTNS in this setting is novel and feasibility-focused.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants must meet all of the following criteria: * Female adults aged 18 years or older. * Diagnosed with overactive bladder syndrome (ICIQ-OAB score ≥10). * Symptoms present for at least three months and refractory to first-line treatments. * Willing to refrain from starting new bladder-related treatments during the study period. * Able and willing to provide written informed consent. Exclusion Criteria: * Participants meeting any of the following criteria will be excluded: * Pregnant or planning pregnancy during the study period. * Bleeding disorders. * Severe needle phobia. * Presence of a pacemaker. * Active cancer diagnosis. * Active urinary tract infections or other urological conditions requiring urgent intervention. * Participation in another clinical trial for bladder dysfunction within the past six months. * Neurological conditions affecting continence (e.g., diabetic neuropathy, multiple sclerosis, Parkinson's disease). * Life-threatening infections. * Severe cognitive deficits, unconsciousness, dementia (e.g., Alzheimer's or other neurodegenerative diseases). * History of incontinence surgery. * Previous acupuncture for OAB within the past two months. * History of thromboses. * Recovering from or suffering from a serious illness or major surgery.
Where it's running
-
Chelsea and Westminster hospital NHS foundation Trust
London, United Kingdom, United Kingdom Recruiting
Study contacts
- Principal investigator: Elmas X Court — Chelsea and Westminster Hospital and Imperial College London
- Study coordinator: Elmas Court
- Email: elmas.court@nhs.net
- Phone: +447538355975
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Compare two bladder medicines and placebo for urgency incontinence in older women
This study tests whether tolterodine ER or mirabegron help with urinary and aging-related outcomes in older women with urgency-predominant incontinence, compared with placebo.
-
Urinary incontinence in older adults: how leakage and bladder residuals relate to frailty
This study tests whether the severity of urinary leakage and leftover urine after voiding are linked to frailty and other geriatric outcomes in older adults visiting a urology clinic.
-
Compare two pelvic floor stimulation devices to see which helps with urinary incontinence in women
We’re testing if electromagnetic chair therapy can help women with mixed urinary incontinence as well as standard electrostimulation with biofeedback.
-
Managing nighttime voiding in older women with sleep strategies
This study tests whether brief behavioral sleep therapy and mindfulness, alone or together, reduce how often older women wake at night to urinate and how much urine they produce at night.
-
Rugby-tailored pelvic floor training to reduce urinary leakage in women rugby players
This study tests whether a rugby-focused pelvic floor training program can reduce urinary incontinence in professional and semi-professional women rugby players who currently leak urine.
-
Community-based approach using digital tools and behavioral guidance for nocturia
This project tests a digital health and behavioral program for adults 55+ with nocturia to see if it reduces night-time voids and improves quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.